US FDA’s Scorching August Agenda

Ten novel agents are among the pending applications with user fee goal dates in August 2018.

Striped beach umbrella on the beach.

The US FDA is expected to render approval decisions on 10 novel agents over the coming month, potentially making August the busiest month for novel approvals in what has already been a busy year.

FDA has already cleared 26 new molecular entities and novel biologics in 2018 – 24 from the Center for Drug...

More from Approvals

More from Product Reviews